Food Allergy Diagnostics & Therapeutics Market by Product Type (Diagnostic Tests Type, Therapeutic Treatment Type), Technology (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction), Source, Component, End-User - Global Forecast 2024-2030

[192 Pages Report] The Food Allergy Diagnostics & Therapeutics Market size was estimated at USD 5.86 billion in 2023 and expected to reach USD 6.43 billion in 2024, at a CAGR 10.35% to reach USD 11.69 billion by 2030.

Food allergy diagnostics & therapeutics include drugs, therapies, and diagnostics that reduce the symptoms of food allergies and help the immune system prepare for future encounters. The rising prevalence of food allergies worldwide is driving the usage of food allergy diagnostics & therapeutics. Symptoms associated with the food allergic response could range from itchiness, swelling of the tongue, or hives to low blood pressure, diarrhea, or vomiting. The common food allergens are eggs, milk, wheat, fish, and tree nuts. In addition, technological advancements and an increase in the number of R&D initiatives being undertaken to develop drugs with higher efficacy are expected to create opportunities for the growth of the food allergy diagnostics & therapeutics market. However, the high cost associated with food allergy diagnostics & treatments makes them unaffordable for people in low-income countries.

The Americas represents a highly developing landscape for the food allergy diagnostics & therapeutics market characterized by the rising development of new diagnostic methods and an increasing number of people suffering from food allergies. According to Food Allergy Research & Education (FARE) data from 2021, one in ten adults and one in 13 children have different food allergies in America. Similarly, 32 million people in the United States have food allergies, and some common food allergens include milk, egg, peanut, tree nuts, wheat, soy, fish, and crustacean shellfish are common in the United States. The market innovators in the region are expanding their R&D activities to increase the development of new and advanced food allergy diagnostic tests. In August 2022, Eurofins Craft Technologies developed a new method to quantify different phenolic acids in foods and supplements. Phenolics are present in fruits, vegetables, grains, oils, and drinks such as coffee, tea, and wine. The increasing number of food testing labs in India, Australia, China, and Japan is expected to expand the scope of the food allergy diagnostic and therapeutics market in Asia-Pacific. In September 2021, SGS SA launched the Advance Center of Testing (ACT) at its Ambattur, Chennai, India laboratory premises, and the ACT provides fast and precise services to the agriculture and food industries.

The market dynamics represent an ever-changing landscape of the Food Allergy Diagnostics & Therapeutics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Growing incidences of allergic conditions among pediatric and adult populations
  • Increasing funds by organizations in food allergy diagnostics
  • Rising patient demand for in vitro diagnostic blood tests
• Market Restraints
  • Limited awareness and less implementation of food allergic testing methods
• Market Opportunities
  • Ongoing technological advancements in food allergy diagnostics and therapeutics
  • Increasing number of research and development initiatives for the development of drugs
• Market Challenges
  • Stringent regulatory framework for food allergy diagnostics and therapeutics

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Food Allergy Diagnostics & Therapeutics Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Food Allergy Diagnostics & Therapeutics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Food Allergy Diagnostics & Therapeutics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

• Aleph Farms Increases Production Capabilities With VBL Therapeutics Facility Acquisition And ESCO Aster Partnership

  Aleph Farms is setting the pace for food allergy diagnostics and therapeutics with the acquisition of VBL Therapeutics' facility and the partnership with Esco Aster. With expertise at the cutting edge of cell-based agricultural science, Aleph Farms is building a comprehensive supply chain that includes everything from origin to final delivery of its products by leveraging best-in-class partnerships. As consumer demand for allergen-free foods continues to rise, this preeminent organization is committed to delivering high quality, faithful alternatives. Aleph Farms’ progress highlights both their ambition and industry confidence in their ability to meet consumer needs with innovation and integrity. [Published On: March 01, 2023]

• Jerath Path Labs expands the reach in India in allergy-testing

  With the market for food allergy diagnostics and therapeutics rapidly expanding, Jerath Path Labs is well-placed to benefit from opportunities this growth presents. Their recent expansion of testing capabilities in India demonstrates their commitment to become a leading provider of allergy testing in the country. Now customers have increased access to quality tests that are cost effective and convenient as they are now offered both at large urban hospitals and in small rural health centers. Jerath Path Labs has demonstrated responsible growth with their careful consideration of the environments they operate in, ensuring reliable results no matter where the test is undertaken. This news is certainly good news for health care providers and patients alike, who will benefit from the improved accessibility of quality allergy testing. [Published On: January 23, 2023]

• Deeside firm secures US patent for food allergy diagnostics

  Reacta Inc. is leading the way in food allergy diagnostics and therapeutics with the recent granting of an exclusive U.S. patent for their technology by the United States Patent and Trademark Office (USPTO). This technology, a rapid test to detect specific food allergies, provides users with detailed information on their food sensitivity as well as a guide to proper dietary management. Reacta's mission is to reduce the chances of severe allergic reactions or avoid them entirely by providing targeted, actionable information to those affected. With this new patent, evidenced-based research and development are now possible enabling more accuracy in the diagnosis process for individuals living with food allergies. Ultimately, this breakthrough will ensure that millions of individuals who suffer from food allergies can live without fear of potential anaphylactic shock. [Published On: August 22, 2022]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Food Allergy Diagnostics & Therapeutics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abelló A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMérieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestlé Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
  • Diagnostic Tests Type
    • In Vitro
    • In Vivo/Skin
      • Patch Test
      • Skin Prick Test
  • Therapeutic Treatment Type
    • Antihistamines
    • Epinephrine Auto-Injector
• Technology
  • Enzyme-Linked Immunosorbent Assay
  • Polymerase Chain Reaction
• Source
  • Eggs
  • Fish
  • Milk
  • Peanuts
  • Shellfish
  • Soy
  • Tree Nuts
  • Wheat
• Component
  • Consumables
  • Instruments
  • Services
• End-User
  • Academic Research Institutes
  • Diagnostics Laboratories
  • Hospitals & Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?